In vitro screening of psychoactive drugs by [(35)S]GTPgammaS binding in rat brain membranes.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biological and Pharmaceutical Bulletin

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 18057721
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.

  2007cited by this paper
• The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats

  2006cited by this paper
• Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPγS binding

  2005cited by this paper
• Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

  2004cited by this paper
• Understanding Drugs and Behaviour

  2004cited by this paper
• Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids.

  2004cited by this paper
• The [35S]GTPgammaS binding assay: approaches and applications in pharmacology.

  2003cited by this paper
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

  2003cited by this paper
• Serotonin Transporters, Serotonin Release, and the Mechanism of Fenfluramine Neurotoxicity

  2000cited by this paper
• Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.

  2000cited by this paper
• Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [35S]GTP gamma S binding.

  1999cited by this paper
• A review of central 5-HT receptors and their function.

  1999cited by this paper
• Pharmacological characterization of dopamine-stimulated [35S]-guanosine 5'(gamma-thiotriphosphate) ([35S]GTPgammaS) binding in rat striatal membranes.

  1999cited by this paper
• N4-unsubstituted N1-arylpiperazines as high-affinity 5-HT1A receptor ligands.

  1995cited by this paper
• The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis

  1995cited by this paper
• Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents.

  1991cited by this paper
• Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes.

  1990cited by this paper
• [125I]-2-(2,5-dimethoxy-4-iodophenyl)aminoethane ([125I]-2C-I) as a label for the 5-HT2 receptor in rat frontal cortex.

  1990cited by this paper
• Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens.

  1988cited by this paper
• Comparison of behavioral properties of di- and tri-methoxyphenylisopropylamines.

  1982cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Toxicology and Pharmacological Interactions of Classic Psychedelics.

  2024cites this paper
• Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.

  2023cites this paper
• Serotonin toxicity of serotonergic psychedelics

  2021cites this paper
• Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans

  2021cites this paper
• Determination of 5-MeO-DIPT in human urine using gas chromatography coupled with high resolution Orbitrap mass spectrometry.

  2020cites this paper
• New Psychoactive Substance 5-MeO-MiPT In vivo Acute Toxicity and Hystotoxicological Study

  2020cites this paper
• Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.

  2018cites this paper
• Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives.

  2017cites this paper
• Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents

  2017cites this paper
• Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.

  2016cites this paper
• Novel N-Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic Potential.

  2015cites this paper
• Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function

  2014cites this paper
• Delirium Due to Intoxication from the Novel Synthetic Tryptamine 5‐MeO‐DALT

  2014cites this paper
• Tolerance and Cross-Tolerance to Head Twitch Behavior Elicited by Phenethylamine- and Tryptamine-Derived Hallucinogens in Mice

  2014cites this paper
• Recreational Use, Analysis and Toxicity of Tryptamines

  2014cites this paper
• [In vitro screening of psychoactive drugs].

  2013cites this paper
• The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): A brief review

  2012cites this paper
• Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part II--piperazines/piperidines, phenylethylamines, tryptamines and miscellaneous 'others'.

  2012cites this paper
• ‘Legal Highs’ – novel and emerging psychoactive drugs: a chemical overview for the toxicologist

  2012cites this paper
• Cardiovascular toxicity of novel psychoactive drugs: lessons from the past.

  2012cites this paper
• Abuse Liability Profile of Three Substituted Tryptamines

  2011cites this paper
• Benzylpiperazine in New Zealand: brief history and current implications

  2011cites this paper
• [Analysis of newly distributed designer drugs detected in the products purchased in fiscal year 2008].

  2010cites this paper
• Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

  2010cites this paper
• [In-vitro screening of psychoactive drugs to prevent abuses].

  2008cites this paper